Best Japanese Stocks To Own Right Now

Stocks went nowhere today after making back early losses, as Chevron (CVX) and Wal-Mart (WMT) gained, while Visa (V) and Boeing (BA) fell.

REUTERS

The S&P 500 gained 0.03% to 1,868.20, while the Dow Jones Industrial Average fell 0.07% to 16,340.08. Chevron’s 1% gain, which came after being added to the Focus List at Credit Suisse, and Wal-Mart’s 0.8% rise helped balance out�Visa’s 0.5% fall and� Boeing’s 1% drop, which came after UBS cut its price target. Tesoro (TSO) jumped 4.1% to $54.50 after oil prices fell, making the refiner the S&P 500′s biggest winner.

Once again, concerns about China are reputed to have driven early weakness in the stock market. Rhino Trading Partners’ Michael Block expresses his concern about the falling Chinese yuan:

…cheaper Chinese exports could wreak havoc on non Chinese exporters around the world.� The most obvious losers would be South Korean, Japanese, U.S. and European stocks that are heavy exporters to countries other than China…In the U.S., I am concerned about export heavy sectors like autos and steel the most.� Given the weaker yuan and lower Chinese purchasing power, consumer companies selling into China, whether they be luxury goods makers or QSRs, are also ones to avoid here.

Best Japanese Stocks To Own Right Now: NuVasive Inc.(NUVA)

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. The company?s products focus on applications for spine fusion surgery. It offers products primarily for the thoracolumbar spine and cervical spine. The company?s principal products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines four categories of product offerings, including NVM5 and NVJJB, its proprietary software-driven nerve monitoring systems; MaXcess system that provides access to the spine with minimal soft tissue disruption; specialized implants that are used for interbody disc height restoration for fusion and stabilization of the spine, as well as biologic products comprising FormaGraft, a collagen-based synthetic bone substitute and Osteocel Plus, an allograft cellular ma trix. Its biologic products also comprise AttraX, a synthetic bone graft material; and Triad, an allograft cellular matrix containing viable mesenchymal stem cells. In addition, the company offers a range of bone allograft in patented saline packaging; disposables and spine implants under the CoRoent brand name; and fixation devices, such as rods, plates, and screws. Further, it provides intra-operative monitoring services for insight into the nervous system during spine and other surgeries. Additionally, the company is developing total disc replacement devices for lateral lumbar spine and cervical spine applications. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Bryan Murphy]

  It may not be as big as NuVasive, Inc. (NASDAQ:NUVA), and it might not be as sexy as MiMedx Group Inc. (NASDAQ:MDXG). But, Bacterin International Holdings Inc. (NYSEMKT:BONE) offers something to investors that MDXG and NUVA don't - can't - right now... a distinct opportunity for a lot of upside in a short amount of time.

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Wednesday’s session are Bank of America Corp.(BAC), Chelsea Therapeutics International Ltd.(CHTP) and NuVasive Inc.(NUVA)

Best Japanese Stocks To Own Right Now: Renasant Corporation(RNST)

Renasant Corporation operates as the bank holding company for the Renasant Bank that provides various financial and insurance services to retail and commercial customers. The company offers checking accounts, money market accounts, savings accounts, certificates of deposit, time deposits, individual retirement accounts, and health savings accounts. It also provides commercial, financial, and agricultural loans; construction loans, including loans for the construction of single family residential properties, multi-family properties, and commercial projects; residential mortgage loans; home equity loans or lines of credit; consumer loans; and equipment leasing, as well as safe deposit and night depository facilities. In addition, the company offers various fiduciary services; and administers qualified retirement plans, profit sharing and other employee benefit plans, personal trusts, and estates. Further, the company provides annuities, mutual funds, and other investment ser vices through a third party broker-dealer. Additionally, the company offers commercial and personal insurance products through carriers. As of October 21, 2011, it operated approximately 75 banking, mortgage, financial services, and insurance offices in Mississippi, Tennessee, Alabama, and Georgia. The company was founded in 1904 and is based in Tupelo, Mississippi.

Advisors' Opinion:

• [By Monica Gerson]

  Renasant (NASDAQ: RNST) is expected to post its Q3 earnings at $0.31 per share on revenue of $60.87 million.

  Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

• [By Rich Duprey]

  Financial services specialist�Renasant� (NASDAQ: RNST  ) �announced yesterday�its second-quarter dividend of $0.17 per share, the same rate it's paid since 2007.

Top 5 Food Companies To Watch In Right Now: Antares Pharma Inc (ATRS)

Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company�� subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR), with Teva and Ferring being its two primary customers. The Company has also licensed both disposable auto and pen injection devices to Teva for use in certain fields and territories and is engaged in product development activities for Teva utilizing these devices.

In the gel-based area, it received Food and Drug Administration (FDA) approval in December 2011 for its oxybutynin gel 3% product, Anturol, for the treatment of overactive bladder. Antares also has a licensing agreement with Watson Watson Pharmaceuticals, Inc. (Watson) under which Watson will commercialize its topical oxybutynin gel 3% product in the United States and Canada. Its gel portfolio also includes Elestrin (estradiol gel) in the United States for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies.

Pressure Assisted Injection Devices

The Company�� Pressure Assisted Injection Devices consists of three products: reusable needle-free injectors, disposable pressure assisted auto injectors and disposable pen injectors. Reusable needle-free injectors deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. The injector employs a disposable pl! astic needle-free syringe, which offers liquid medication delivery through an opening that is approximately half the diameter of a standard, 30-gauge needle.

Disposable pressure assisted auto injectors is a technology of controlled pressure delivery of drugs into the body utilizing a spring power source. The Vibex is designed to provide fast subcutaneous or intramuscular injections of up to 0.5ml with minimal discomfort and improved convenience in conjunction with the enhanced safety of a shielded needle. Disposable pen injectors are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The devices contain mechanisms that specify the dose to be delivered by defining the amount of movement by the stopper in the cartridge with each device actuation.

The Vision/Tjet has been sold for use in more than 30 countries to deliver either insulin or hGH. The product features a reusable, spring-based power source and disposable needle-free syringe, which acts as the pathway for the injectable drug through the skin and allows for viewing of the medication dose prior to injection. The product is also reusable, with each device designed to last for approximately 3,000 injections (or approximately two years) while the needle-free syringe, when used with insulin or hGH, is disposable after approximately one week when used by a single patient for injecting from multi-dose vials. The Vision/Tjet administers injectables by using a spring to push the active ingredient in solution or suspension through a micro-fine opening in the needle-free syringe. The opening is approximately half the diameter of a 30-gauge needle. The Vision/Tjet is primarily used in the United States, Europe, Asia and Japan.

Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies. Its Vibex disposable product combines a low-energy, spr! ing-based! power source with a hidden needle, which delivers up to 0.5ml of the needed drug solution subcutaneously or intramuscularly. Antares is also developing a Vibex MTX auto injector for delivery of methotrexate for treatment of rheumatoid arthritis. The Company�� multi use, disposable pen injector complements its portfolio of single-use pressure assisted auto injector devices. The disposable pen injector device is designed to deliver drugs by injection through needles from multi- dose cartridges. The disposable pen is in the stage of development where devices are being used in clinical evaluations.

Transdermal Products

The Company�� ATD system penetrates the skin to deliver a variety of treatments. The gels consist of a hydro-alcoholic base, including a combination of permeation enhancers. Products being developed/ commercialized include Anturol, Elestrin and Nestragel. Elestrin is a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Its other injectable drugs that are presently self-administered and may be suitable for injection with its systems include therapies for the prevention of blood clots and treatments for multiple sclerosis, migraine headaches, inflammatory diseases, impotence, infertility, acquired immune deficiency symdrome (AIDS) and hepatitis.

The Company competes with Ypsomed AG, SHL Group AB, OwenMumford Ltd., West Pharmaceuticals, Becton Dickinson, Haselmeir GmbH, Elcam Medical, Vetter Pharma, Bioject Medical Technologies Inc., The Medical House PLC, Watson, Abbott, Eli Lilly, Auxillium, Inc., Endo Pharmaceuticals, Teva, Mylan, Roxane, Bedford Labs, APP Pharmaceuticals, Hospira, Pfizer, GSK/Astellas, Warner Chilcott and Allergan.

Advisors' Opinion:

• [By Bryan Murphy]

  This is NOT a judgment call on the drug. This isn't a judgment call on the company either. This is a judgment call on how emotional and distracted traders can get from time to time, and we only have to look at Antares Pharma Inc. (NASDAQ:ATRS), Avanir Pharmaceuticals Inc. (NASDAQ:AVNR), and VIVUS, Inc. (NASDAQ:VVUS) to see how drinking the proverbial Kool-Aid ultimately punished anyone who bought rather than sold ATRS, VVUS, and AVNR right when the news seemed to incredibly encouraging.

• [By Keith Speights]

  Antares Pharma (NASDAQ: ATRS  ) announced its first-quarter results �Wednesday morning but failed to impress the market. Shares were down around 3% in midday trading. Here are the highlights from the company's results.

Best Japanese Stocks To Own Right Now: DaVita HealthCare Partners Inc (DVA)

DaVita HealthCare Partners Inc., formerly DaVita Inc., incorporated on April 4, 1994, is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In addition, as of December 31, 2011, it provided dialysis and administrative services to a total of 11 outpatient dialysis centers located in three countries outside of the United States. On September 2, 2011, the Company acquired CDSI I Holding Company, Inc., the parent company of dialysis provider DSI Renal Inc. In November 2011, the Company announced that its wholly owned European subsidiary, DV Care GmbH, acquired ExtraCorp AG. In January 2012, the Company acquired controlling interest in NephroLife. In September 2012, the Company announced that its new guest services contact center located in Centennial, Colorado was opened. On November 1, 2012, the Company announced the consummation of the merger of HealthCare Partners Holdings, LLC (HCP), with Seismic Acquisition LLC, a wholly owned subsidiary of the Company, with HCP as the surviving entity (the Merger). The Merger, HCP became a wholly owned subsidiary of the Company. In January 2013, the Company acquired nine dialysis centers from Fresenius Medical Care (FMC), provider of dialysis services and manufacturer of dialysis products.

During the year ended December 31, 2011, the Company acquired a total of 178 dialysis centers, eight of which were located outside of the United States, opened 65 new dialysis centers, sold two centers, merged seven centers, and divested a total of 30 dialysis cent! ers in connection with the acquisition of DSI. It also added three dialysis centers under management and administrative service agreements that are located outside of the United States and added one center in which the Company owns a minority equity interest. The Company�� United States dialysis and related laboratory services business accounts for approximately 93% of its consolidated net operating revenues. Its other ancillary services accounted for approximately 7% of its consolidated net operating revenues during the year ended December 31, 2011.

Dialysis and Related Lab Services

As of December 31, 2011, the Company operated or provided administrative services through a network of 1,809 outpatient dialysis centers located in the United States and 11 outpatient dialysis centers located outside the United States that are designed specifically for outpatient hemodialysis. Many of the Company�� outpatient dialysis centers offer certain support services for dialysis patients who prefer and are able to perform either home-based hemodialysis or peritoneal dialysis in their homes. Home-based hemodialysis support services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance. Registered nurses train patients and their families or other caregivers to perform either home-based hemodialysis or peritoneal dialysis.

As of December 31, 2011, the Company provided hospital inpatient hemodialysis services, excluding physician services, to patients in approximately 900 hospitals throughout the United States. It renders these services for a contracted per-treatment fee that is individually negotiated with each hospital. When a hospital requests the Company�� services, the Company administers the dialysis treatment at the patient�� bedside or in a dedicated treatment room in the hospital, as needed. In 2011, hospital inpatient hemodialysis services accounted for approximately 4.5% of its total United S! tates dia! lysis treatments. The Company owns two licensed clinical laboratories, which specialize in ESRD patient testing. These laboratories provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients. Its laboratories provide these tests primarily for its network of ESRD patients throughout the United States. These tests are performed to monitor a patient�� ESRD condition, including the adequacy of dialysis, as well as other medical conditions. During 2011, it operated or provided management and administrative services to 33 outpatient dialysis centers located in the United States and three outpatient dialysis centers located outside of the United States, in which it either owns a minority equity investment or are wholly owned by third parties. These services are provided pursuant to management and administrative services agreements.

Ancillary services and strategic initiatives

DaVita Rx is a pharmacy that provides oral medications to DaVita�� patients with ESRD. HomeChoice Partners provides personalized infusion therapy services to patients typically in their own. Intravenous and nutritional support therapies are typically managed by registered and/or board-certified professionals, including pharmacists, nurses and dieticians in collaboration with the patient�� physician in support of the patient�� ongoing health care needs. VillageHealth provides advanced care management services to health plans and Government agencies for employees/members diagnosed with Chronic Kidney Disease (CKD) or ESRD. Lifeline provides management and administrative services to physician-owned vascular access clinics that provide surgical and interventional radiology services for dialysis patients. Lifeline also is the owner of one vascular access clinic. DaVita Clinical Research conducts research trials principally with dialysis patients and provides administrative support for research conducted by DaVita-affiliated nephrology practices. DaVita Neph! rology Pa! rtners offers practice management and administrative services to physicians who specialize in nephrology. Practice management and administrative services include operations management, information technology support, billing and collections, credentialing and coding, and other support functions.

The Company competes with Fresenius Medical Care.

Advisors' Opinion:

• [By Lauren Pollock]

  DaVita Healthcare Partners Inc.(DVA) and Fresenius Medical Care AG(FME.XE) & Co. traded higher after the Centers for Medicare and Medicaid Services said it will reduce payments to kidney dialysis providers by less than 1% over the next two years in a reversal of the much-larger cuts it had proposed earlier this summer. The move handed at least a temporary victory to dialysis providers like DaVita and Fresenius. DaVita’s shares jumped 4.4% to $59 premarket, while Fresenius’ stock climbed 7.7% to $34.71.

Best Japanese Stocks To Own Right Now: The York Water Company(YORW)

The York Water Company engages in impounding, purifying, and distributing drinking water in Pennsylvania. It has two reservoirs, Lake Williams and Lake Redman, which together holds up to approximately 2.2 billion gallons of water. The company also has a 15-mile pipeline from the Susquehanna River to Lake Redman that provides access to an additional supply of 12.0 million gallons of water per day. As of December 31, 2010, it served 182,000 residential, commercial, industrial, and other customers in 39 municipalities in York County and 7 municipalities in Adams County. The company was founded in 1816 and is based in York, Pennsylvania.

Advisors' Opinion:

• [By David Dittman]

  Question: I like the H2O business. I��e owned American Water Works Co Inc (NYSE: AWK) for eons. Is there any compelling reason to own more than one water utility? At what point does is there no marginal benefit added? I do like Connecticut Water Service Inc (NSDQ: CTWS) and York Water Co (NSDQ: YORW) as slow, consistent growers.
  
  As Ben Franklin said, ��ittle strokes fell great oaks.��/p>

Best Japanese Stocks To Own Right Now: DIRECTV(DTV)

DIRECTV provides digital television entertainment in the United States and Latin America. The company provides direct-to-home (DTH) digital television services, as well as multi-channel video programming distribution services in the United States. It offers various channels of digital-quality video entertainment and CD-quality audio programming directly to subscribers' homes or businesses, as well as video-on-demand services; and approximately 160 national high-definition television channels and 4 3D channels. The company also provides premium professional and collegiate sports programming, such as the NFL SUNDAY TICKET package, which allows subscribers to view the NFL games. In addition, it offers DTH digital television services in Latin America and the Caribbean, including Puerto Rico. The company provides its local and international programming under the DIRECTV and SKY brand names. As of December 31, 2010, it served approximately 19.2 million subscribers in the United States; and 8.9 million subscribers in Latin America. The company was founded in 1990 and is based in El Segundo, California.

Advisors' Opinion:

• [By Roadmap2Retire]

  Investing in AT&T bolsters my portfolio with more exposure to the telecom sector - which I am bullish on. The company is the leader in the telecom world, but the current environment provides for some interesting points. Some of the factors that contributed in my decision to initiate this position.

  Dividend income - AT&T provides great current income with prospects of dividend growth in the future. Dogs of the Dow - Some people use this investing strategy to beat the market. While my main goal is not to beat the market, this strategy provides some visibility into the under-to-fairly valued stocks in the DJIA. The strategy, for those unfamiliar, is simply to invest in the highest yielders of the DJIA called the Dogs of the Dow. AT&T is the currently the highest yielder in DJIA. Solid revenue growth & EPS growth: After minimal gains from 2009-2012 in revenue, and a dip in diluted EPS from 2010 to 2011, AT&T has turned the ship around and the current trend is pointing upward. DirecTV (DTV) acquisition - AT&T announced that it intends to acquire DTV, which could provide with considerable amount of revenue growth in the future. Possibility of REIT spinoff - The recent news of Windstream (WIN) spinning off a publicly traded REIT resulted in speculation that other telecom providers would follow suit. If AT&T follows in the footsteps of WIN, that would result in unlocking a lot of value for shareholders. In-Car 4G LTE - AT&T has been at the forefront in this field having secured deals with car manufacturers such as Audi, Tesla (TSLA), General Motors (GM) etc. AT&T could potentially add millions of new subscribers to their customer base as the current and future generation of cars come with a 4G LTE-capability.

  The bottom line is that the companies that control the data pipes in an ever-connected and integrated digital world will command the marketplace. Telecom service providers (alongside cable service providers) will be able to

• [By WALLSTCHEATSHEET]

  DirecTV is a digital television entertainment company that offers satellite services to consumers and companies across the nation. The company is trying to attain�exclusive licensing rights to all NFL Sunday afternoon games. The stock has been trending higher in recent years and is now trading slightly below all-time highs. Over the last four quarters, earnings and revenues have been rising, leaving investors pleased about recent earnings announcements. Relative to its peers and sector, DirecTV has been a relative performance leader in the year to date. Look for DirecTV to OUTPERFORM.

• [By Jonathan Berr]

  DirecTV (DTV) has made some of the funniest commercials in recent memory, and after the company�� most recent earnings report, it�� laughing all the way to the bank.

• [By Chris Hill]

  DirecTV (NASDAQ: DTV  ) hits a new all-time high, as the satellite-TV provider now has more than 20 million U.S. subscribers. Bank of America (NYSE: BAC  ) hits a two-year high in the wake of a $1.7 billion settlement with mortgage insurer MBIA. MercadoLibre's (NASDAQ: MELI  ) first-quarter revenue rises 23% and shares hit an all-time high. And First Solar (NASDAQ: FSLR  ) loses some energy on lower-than-expected earnings. In this installment of�Investor Beat, our analysts talk about four stocks making moves.

Best Japanese Stocks To Own Right Now: NIC Inc. (EGOV)

NIC Inc. provides eGovernment services that enable governments use the Internet to provide various services to businesses and citizens in the United States. It operates in two segments, Portal Outsourcing, and Software and Services. The Portal Outsourcing segment enters into long-term contracts with governments to design, build, and operate Web-based enterprise-wide portals on their behalf. These portals consist of Web sites and applications that enable businesses and citizens to access government information online and complete transactions, including applying for a permit, retrieving driver?s history records, and filing a government-mandated form or report. The Software and Services segment involves in the software development and services to state and local governments, and federal agencies; development and management of the national motor carrier pre-employment screening program; design and development of online campaign expenditure and ethics compliance systems for fe deral and state government agencies; and provision of software applications and services for electronic filings and document management for the California Secretary of State. It also provides consulting, application development, and portal management services to governments. The company was founded in 1991 and is headquartered in Olathe, Kansas.

Advisors' Opinion:

• [By CRWE]

  NIC Inc.(NASDAQ:EGOV), the nation�� premier provider of eGovernment services, will discuss its 2012 second quarter financial results via a conference call on Thursday, August 2, 2012 at 4:30 p.m. (EDT), with the news release issued at 4 p.m. (EDT) the same day.

• [By Michael A. Robinson]

  Indeed, NIC Inc. (Nasdaq: EGOV) is an expert at building government websites that operate flawlessly. It counts 3,500 government agencies as e-government clients.

Best Japanese Stocks To Own Right Now: African Barrick Gold PLC (ABGLF)

African Barrick Gold plc (ABG) is a United Kingdom-based company. The Company is a gold producer in Tanzania. Its operations include exploration and development to mine construction and operation. ABG has resources of approximately 32 million ounces of gold. The Company has three producing mines, all located in northwest Tanzania: Bulyanhulu, Buzwagi and North Mara, and several exploration projects at various stages of development in Tanzania and Kenya. Bulyanhulu is an underground gold mine. Buzwagi is an open pit gold mine. North Mara is an open pit gold mine consisting of three open pit deposits. Advisors' Opinion:

• [By Ben Levisohn]

  Over the last several months, ABX has been divesting non-core assets. Starting in mid-2013, the company sold its non-core energy assets. Since then, focus has been on selling Australian gold assets. As we have stated previously, we believe the company will continue to sell noncore assets, focusing primarily on its interests in North America. Barrick had been previously seeking a suitor for its 74% interest in African Barrick (ABGLF); to date, the company remains unsuccessful in disposition of the ABG interest. In addition, we would not be averse to seeing Barrick sell off some or all of its copper assets, if they can get the right price.